The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie
Abstract
In prion and Alzheimer's diseases, the roles played by amyloid versus nonamyloid deposits in brain damage remain unresolved. In scrapie-infected transgenic mice expressing prion protein (PrP) lacking the glycosylphosphatidylinositol (GPI) membrane anchor, abnormal protease-resistant PrPres was deposited as amyloid plaques, rather than the usual nonamyloid form of PrPres. Although PrPres amyloid plaques induced brain damage reminiscent of Alzheimer's disease, clinical manifestations were minimal. In contrast, combined expression of anchorless and wild-type PrP produced accelerated clinical scrapie. Thus, the PrP GPI anchor may play a role in the pathogenesis of prion diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mice devoid of PrP are resistant to scrapie
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., & Weissmann, C. (1993) · Cell · doi:10.1016/0092-8674(93)90360-3 · Cited by 2,100
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Self-citationA cellular gene encodes scrapie PrP 27-30 protein
Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90333-2 · Cited by 1,513
Scrapie prion protein contains a phosphatidylinositol glycolipid
STAHL, N. (1987) · Cell · doi:10.1016/0092-8674(87)90150-4 · Cited by 1,112
Cell-free formation of protease-resistant prion protein
Kocisko, D. A., Come, J. H., Priola, S. A., Chesebro, B., Raymond, G. J., Lansbury, P. T., & Caughey, B. (1994) · Nature · doi:10.1038/370471a0 · Cited by 883
Self-citationFischer, M., Rülicke, T., Raeber, A., Sailer, A., Moser, M., Oesch, B., Brandner, S., Aguzzi, A., & Weissmann, C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00467.x · Cited by 877
Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene
Basler, K., Oesch, B., Scott, M., Westaway, D., Wälchli, M., Groth, D. F., McKinley, M. P., Prusiner, S. B., & Weissmann, C. (1986) · Cell · doi:10.1016/0092-8674(86)90662-8 · Cited by 835
Normal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 810
Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P.-C., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 770
Caughey, B., & Raymond, G. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55257-1 · Cited by 637
Self-citationENCEPHALOPATHY IN MICE PRODUCED BY INOCULATION WITH SCRAPIE BRAIN MATERIAL
Chandler, R. L. (1961) · The Lancet · doi:10.1016/s0140-6736(61)92008-6 · Cited by 521
Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain
Chesebro, B., Race, R., Wehrly, K., Nishio, J., Bloom, M., Lechner, D., Bergstrom, S., Robbins, K., Mayer, L., Keith, J. M., et al. (1985) · Nature · doi:10.1038/315331a0 · Cited by 500
Self-citationBudka, H., Aguzzi, A., Brown, P., Brucher, J., Bugiani, O., Gullotta, F., Haltia, M., Hauw, J., Ironside, J. W., Jellinger, K., et al. (1995) · Brain Pathology · doi:10.1111/j.1750-3639.1995.tb00625.x · Cited by 428
Bruce, M. E., McConnell, I., Fraser, H., & Dickinson, A. G. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-3-595 · Cited by 388
Masliah, E., Sisk, A., Mallory, M., Mucke, L., Schenk, D., & Games, D. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-18-05795.1996 · Cited by 370
Self-citationCross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo
Solforosi, L., Criado, J. R., McGavern, D. B., Wirz, S., Sánchez-Alavez, M., Sugama, S., DeGiorgio, L. A., Volpe, B. T., Wiseman, E., Abalos, G., et al. (2004) · Science · doi:10.1126/science.1094273 · Cited by 366
Self-citationGenetic influence on the structural variations of the abnormal prion protein
Parchi, P., Zou, W., Wang, W., Brown, P., Capellari, S., Ghetti, B., Kopp, N., Schulz-Schaeffer, W. J., Kretzschmar, H. A., Head, M. W., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10168 · Cited by 330
Hope, J., Morton, L. J., Farquhar, C. F., Multhaup, G., Beyreuther, K., & Kimberlin, R. H. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04539.x · Cited by 325
Ghetti, B., Piccardo, P., Spillantini, M. G., Ichimiya, Y., Porro, M., Perini, F., Kitamoto, T., Tateishi, J., Seiler, C., Frangione, B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.744 · Cited by 281
Caughey, B., Brown, K., Raymond, G. J., Katzenstein, G. E., & Thresher, W. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2135-2141.1994 · Cited by 237
Self-citationKaneko, K., Vey, M., Scott, M., Pilkuhn, S., Cohen, F. E., & Prusiner, S. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2333 · Cited by 236
Wong, C. '. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.377 · Cited by 235
Pathogenesis, diagnosis and treatment of systemic amyloidosis
Pepys, M. B. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0766 · Cited by 233
Horiuchi, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.12.3193 · Cited by 226
Tagliavini, F., Prelli, F., Ghiso, J., Bugiani, O., Serban, D., Prusiner, S. B., Farlow, M. R., Ghetti, B., & Frangione, B. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07977.x · Cited by 199
Ghetti, B., Piccardo, P., Frangione, B., Bugiani, O., Giaccone, G., Young, K., Prelli, F., Farlow, M. R., Dlouhy, S. R., & Tagliavini, F. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00796.x · Cited by 193
Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells.
Rogers, M., Yehiely, F., Scott, M., & Prusiner, S. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3182 · Cited by 174
Introduction to the transmissible spongiform encephalopathies or prion diseases
Chesebro, B. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.1 · Cited by 168
Self-citationScrapie Strain Variation and Its Implications
Bruce, M. E., & Fraser, H. (1991) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-76540-7_8 · Cited by 151
Cellular Heparan Sulfate Participates in the Metabolism of Prions
Ben-Zaken, O., Tzaban, S., Tal, Y., Horonchik, L., Esko, J. D., Vlodavsky, I., & Taraboulos, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301152200 · Cited by 142
Neurofibrillary Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein
Masliah, E., Sisk, A., Mallory, M. E., & Games, D. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.4.357 · Cited by 136
Self-citationA transgenic mouse model for measles virus infection of the brain
Rall, G. F., Manchester, M., Daniels, L. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4659 · Cited by 135
Soluble Dimeric Prion Protein Binds PrPSc In Vivo and Antagonizes Prion Disease
Meier, P., Genoud, N., Prinz, M., Maissen, M., Rülicke, T., Zurbriggen, A., Raeber, A. J., & Aguzzi, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00201-0 · Cited by 130
Sulfated glycosaminoglycans in amyloid plaques of prion diseases
Snow, A. D., Kisilevsky, R., Willmer, J., Prusiner, S. B., & DeArmond, S. J. (1989) · Acta Neuropathologica · doi:10.1007/bf00687367 · Cited by 124
Scrapie‐specific neuronal lesions are independent of neuronal PrP expression
Jeffrey, M., Goodsir, C. M., Race, R., & Chesebro, B. W. (2004) · Annals of Neurology · doi:10.1002/ana.20093 · Cited by 106
Self-citationMcBride, P., Wilson, M., Eikelenboom, P., TUNSTALL, A. M., & Bruce, M. E. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6740 · Cited by 74
Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<224::aid-ana12>3.0.co;2-w
Cited by
A General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,057
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host
Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., Neuenschwander, A., Abramowski, D., Frey, P., Jaton, A. L., et al. (2006) · Science · doi:10.1126/science.1131864 · Cited by 971
Cellular strategies for controlling protein aggregation
Tyedmers, J., Mogk, A., & Bukau, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2993 · Cited by 896
Protein aggregation diseases: pathogenicity and therapeutic perspectives
Aguzzi, A., & O'Connor, T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3050 · Cited by 762
Metadata
- Authors
- Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S., Caughey, B., Masliah, E., & Oldstone, M.
- Venue
- Science
- Published
- 2005-06-03
- Volume
- 308
- Issue
- 5727
- Pages
- 1435-1439
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2158707059
- Cited by
- 652
- References
- 38
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.